Plus, Tia expands women’s health clinics in San Francisco area
To view this email as a web page, click here

Welcome to FierceHealthcare Weekly Digest, your roundup of the biggest and most popular stories from each of our publications.

Featured Story

Ex-Cerebral executive files lawsuit claiming the startup overprescribed ADHD meds

A former executive at Cerebral, a well-funded online mental health startup, claims in a labor lawsuit that the company fired him after he complained about unlawful business practices.

read more

Top Stories Of The Week

Tia expanding its women's health clinics into Bay Area with major UCSF Health partnership

Tia, a startup building what it calls a "modern medical home for women," inked its second major partnership with a U.S. hospital system to expand access to women's health. The startup on Monday opened its flagship San Francisco clinic, the first in the Bay Area, at the historic 1500 Mission building.

read more

Cerebral stops prescribing Adderall for new ADHD patients as reports of DEA investigation surface

Telehealth startup Cerebral said Wednesday it would stop writing prescriptions for Adderall, Ritalin and other controlled substances to new ADHD patients. The problems at Cerebral intensified Wednesday as Insider reported that the Drug Enforcement Agency (DEA) is investigating the company.

read more

As Teladoc shares tumbled after dismal Q1 earnings, analysts question telehealth giant's growth strategy

Telehealth giant Teladoc warned of a weak sales outlook for 2022 and some analysts are now questioning the company's long-term growth prospects as it faces competitive headwinds.

read more

CVS study: Mental health concerns on the rise as pandemic drags on

Mental health concerns are on the rise across the board, and especially among Blacks, seniors, young adults and LGBTQIA people, a new survey finds.

read more

UnitedHealthcare adopts limited coverage policy for Aduhelm

The health insurance giant's coverage policy aligns with Medicare's recent coverage determination, with the insurer saying it will cover the drug for people in clinical trials and will require prior authorization.

read more

OIG report reignites lawmakers' push for action on Medicare Advantage prior authorization

A major new report from an HHS watchdog on prior authorization denials in Medicare Advantage sparked an urgent effort to get Congress to act on the issue.

read more

Hello Heart notches $70M to scale up cardiovascular health app among employers

Hello Heart, a startup that helps people manage their heart health at home using their smartphones, is seeing a spike in demand among employers for digital cardiovascular solutions. The startup banked a $70 million financing round to help fuel its growth.

read more

Cigna launching provider consult service for oncology care

Cigna is launching a new provider consult service that aims to improve outcomes for patients with cancer.

read more

CVS Health hits 44M unique digital customers in Q1

The healthcare giant also beat the Street on revenue, posting $76.8 billion for the first quarter.

read more

Resources

Whitepaper: The 5 Myths of Diabetes Reversal

Can diabetes truly be reversed? The journey to diabetes remission is not “one size fits all”. By taking a holistic and realistic approach, we see our members achieve a 33% greater reduction in A1C when we treat them for diabetes and depression simultaneously. Combatting the myths of diabetes reversal will serve to improve outcomes of diabetes treatment and develop comprehensive support for individuals with diabetes. Download The 5 Myths of Diabetes Reversal to learn more.

Report: Future of Digital Transformation Report

Download the Future of Digital Transformation Report to discover 4 key action points to transform the patient and care team experience.

Events